Implicaciones de la pandemia por COVID-19 sobre el cáncer en España
Open Access
- 8 May 2020
- journal article
- research article
- Published by Elsevier BV in Medicina Clinica
- Vol. 155 (6), 263-266
- https://doi.org/10.1016/j.medcli.2020.04.011
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- COVID-19 and Cancer: Lessons From a Pooled Meta-AnalysisJCO Global Oncology, 2020
- Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, ChinaAnnals of Oncology, 2020
- SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, ChinaJAMA Oncology, 2020
- Does the COVID-19 outbreak identify a broader need for an urgent transformation of cancer clinical trials research?Contemporary Clinical Trials, 2020
- Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in ItalyJAMA, 2020
- Coronaviruses and Immunosuppressed Patients: The Facts During the Third EpidemicLiver Transplantation, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studiesThe Lancet Oncology, 2011